Standard-dose tegafur-uracil (UFT) is not a safe alternative in partial dihydropyrimidine dehydrogenase-deficient patients.

MJ Deenen, A. Cats, J.H. Beijnen, J.H.M. Schellens

Research output: Contribution to journal › Article › Academic › peer-review

Cite this

@article{887d85cf9e8d41f1b957e75cbe075793,

title = "Standard-dose tegafur-uracil (UFT) is not a safe alternative in partial dihydropyrimidine dehydrogenase-deficient patients.",

author = "MJ Deenen and A. Cats and J.H. Beijnen and J.H.M. Schellens",

year = "2013",

language = "Undefined/Unknown",

volume = "5",

pages = "91--2",

journal = "Ther Adv Med Oncol",

number = "1",

}